James E. Flynn - Insider Trading & Ownership

Entity
Individual
Location
780 Third Avenue, 37 Th Floor, New York, New York
Summary
The estimated net worth of James E. Flynn is at least $2.07B dollars as of March 19, 2024. James E. Flynn is the Director, Director by deputization, More than 10% owner of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) worth about $1.52B. James E. Flynn is the Director, * Director by Deputization, More than 10% owner of Larimar Therapeutics, Inc. and owns shares of Larimar Therapeutics, Inc. (LRMR) worth about $186M. James E. Flynn is the *Possible Member of 10% Group, More than 10% owner of AdaptHealth Corp. and owns shares of AdaptHealth Corp. (AHCO) worth about $142M. James E. Flynn is the * Possible Member of 10% Group, More than 10% owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) worth about $91M. James E. Flynn is the Director, Director by Deputization, More than 10% owner of CareMax, Inc. and owns shares of CareMax, Inc. (CMAX) worth about $54.7M. James E. Flynn is the Director, Director by deputization, More than 10% owner of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) worth about $41.9M. James E. Flynn is the Possible Members of 10% Group, More than 10% owner of Oncology Institute, Inc. and owns shares of Oncology Institute, Inc. (TOI) worth about $19.8M. James E. Flynn is the Director, Director by Deputization, More than 10% owner of Acutus Medical, Inc. and owns shares of Acutus Medical, Inc. (AFIB) worth about $4.16M. James E. Flynn is the Possible Member of 10% Group, More than 10% owner of PepGen Inc. and owns shares of PepGen Inc. (PEPG) worth about $3.97M. James E. Flynn is the *Possible Member of 10% Group, More than 10% owner of Singular Genomics Systems, Inc. and owns shares of Singular Genomics Systems, Inc. (OMIC) worth about $3.86M. James E. Flynn is the Director, *Director by Deputization, More than 10% owner of BiomX Inc. and owns shares of BiomX Inc. (PHGE) worth about $2.08M. James E. Flynn is the Possible Member of 10% Group, More than 10% owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) worth about $1.9M.
All Insider Reports
All Insider Reports

Ownership of James E. Flynn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NUVL Nuvalent, Inc. Director, Director by deputization, More than 10% owner $1.52B Jun 15, 2023
LRMR Larimar Therapeutics, Inc. Director, * Director by Deputization, More than 10% owner $186M +$37.5M +25.3% Feb 16, 2024
AHCO AdaptHealth Corp. *Possible Member of 10% Group, More than 10% owner $142M -$3.82M -2.62% Mar 8, 2024
MIRM Mirum Pharmaceuticals, Inc. * Possible Member of 10% Group, More than 10% owner $91M Jun 6, 2022
CMAX, CMAXW CareMax, Inc. Director, Director by Deputization, More than 10% owner $54.7M Nov 17, 2023
SPRY ARS Pharmaceuticals, Inc. Director, Director by deputization, More than 10% owner $41.9M Nov 8, 2022
TOI, TOIIW Oncology Institute, Inc. Possible Members of 10% Group, More than 10% owner $19.8M Nov 12, 2021
AFIB Acutus Medical, Inc. Director, Director by Deputization, More than 10% owner $4.16M Jun 30, 2022
PEPG PepGen Inc. Possible Member of 10% Group, More than 10% owner $3.97M May 10, 2022
OMIC Singular Genomics Systems, Inc. *Possible Member of 10% Group, More than 10% owner $3.86M Jun 1, 2021
PHGE, PHGE-UN BiomX Inc. Director, *Director by Deputization, More than 10% owner $2.08M Mar 15, 2024
XLO Xilio Therapeutics, Inc. Possible Member of 10% Group, More than 10% owner $1.9M Oct 26, 2021
FRACTYL HEALTH, INC. Possible Members of 10% Group, More than 10% owner Feb 6, 2024
Frazier Lifesciences Acquisition Corp Possible Member of 10% Group, More than 10% owner Nov 8, 2022
ONCR Oncorus, Inc. Possible Member of 10% Group, More than 10% owner Dec 28, 2022

Insider Transactions Reported by James E. Flynn:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership